Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Shares Outstanding (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Shares Outstanding data on record, last reported at $3.4 million in Q3 2025.

  • For Q3 2025, Shares Outstanding fell 87.58% year-over-year to $3.4 million; the TTM value through Sep 2025 reached $3.4 million, down 87.58%, while the annual FY2024 figure was $3.4 million, 77.29% down from the prior year.
  • Shares Outstanding reached $31.0 million in Q3 2025 per FBIO's latest filing, up from $29.8 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $668.8 million in Q3 2022 and bottomed at $3.4 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $55.6 million, with a median of $6.8 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: skyrocketed 183119.45% in 2022, then tumbled 98.66% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $6.8 million in 2021, then plummeted by 49.32% to $3.4 million in 2022, then soared by 340.4% to $15.1 million in 2023, then skyrocketed by 84.91% to $27.9 million in 2024, then plummeted by 87.72% to $3.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $3.4 million in Q3 2025, $3.4 million in Q2 2025, and $3.4 million in Q1 2025.